Rapid EGFR mutation testing in lung cancer tissue samples using a fully automated system and single-use cartridge
Introduction: Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer (NSCLC) patients predicts response to EGFR tyrosine kinase inhibitors (TKIs). The Idylla™ system (Biocartis, Mechelen, Belgium) is a fully integrated, ca...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-05-01
|
Series: | Practical Laboratory Medicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352551719300976 |